Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Recursion Pharmaceuticals, Inc. (RXRX : NSDQ)
 
 • Company Description   
Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

Number of Employees: 800

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.72 Daily Weekly Monthly
20 Day Moving Average: 26,920,320 shares
Shares Outstanding: 406.49 (millions)
Market Capitalization: $2,323.12 (millions)
Beta: 0.91
52 Week High: $12.36
52 Week Low: $3.79
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 10.54% 6.40%
12 Week 3.91% -12.60%
Year To Date -15.46% -20.83%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
41S RIO GRANDE STREET
-
SALT LAKE CITY,UT 84101
USA		 ph: 385-269-0203
fax: 801-821-2872		 investor@recursion.com http://www.recursion.com
 
 • General Corporate Information   
Officers
Christopher Gibson - Chief Executive Officer and Director
Robert Hershberg - Chairman
Ben Taylor - Chief Financial Officer
Zachary Bogue - Director
Blake Borgeson - Director

Peer Information
Recursion Pharmaceuticals, Inc. (CORR.)
Recursion Pharmaceuticals, Inc. (RSPI)
Recursion Pharmaceuticals, Inc. (CGXP)
Recursion Pharmaceuticals, Inc. (BGEN)
Recursion Pharmaceuticals, Inc. (GTBP)
Recursion Pharmaceuticals, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 75629V104
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
Share - Related Items
Shares Outstanding: 406.49
Most Recent Split Date: (:1)
Beta: 0.91
Market Capitalization: $2,323.12 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.32 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.34 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 12.56% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.49
Price/Cash Flow: -
Price / Sales: 38.85
EPS Growth
vs. Year Ago Period: -28.21%
vs. Previous Quarter: 5.66%
Sales Growth
vs. Year Ago Period: 6.89%
vs. Previous Quarter: 224.35%
ROE
06/30/25 - -
03/31/25 - -74.70
12/31/24 - -72.88
ROA
06/30/25 - -
03/31/25 - -54.02
12/31/24 - -52.86
Current Ratio
06/30/25 - -
03/31/25 - 4.11
12/31/24 - 3.81
Quick Ratio
06/30/25 - -
03/31/25 - 4.11
12/31/24 - 3.81
Operating Margin
06/30/25 - -
03/31/25 - -961.32
12/31/24 - -788.02
Net Margin
06/30/25 - -
03/31/25 - -961.32
12/31/24 - -788.02
Pre-Tax Margin
06/30/25 - -
03/31/25 - -962.17
12/31/24 - -789.93
Book Value
06/30/25 - -
03/31/25 - 2.30
12/31/24 - 2.61
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.02
12/31/24 - 0.02
Debt-to-Capital
06/30/25 - -
03/31/25 - 1.73
12/31/24 - 1.81
 

Powered by Zacks Investment Research ©